US Tech 100

18,318.00

0.95%

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Marker Therapeutics (delisted) (TPIV)
Marker Therapeutics (delisted) (TPIV) News

TPIV

TapImmune, Inc. (TPIV)

Marker Therapeutics (delisted)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TPIV

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
10/19/2018	5:10PM	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/19/2018	4:55PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/19/2018	4:53PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/19/2018	4:34PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/19/2018	4:33PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/19/2018	4:31PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/18/2018	4:54PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/18/2018	4:54PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/18/2018	4:54PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/18/2018	4:54PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/18/2018	4:53PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/18/2018	4:52PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/18/2018	4:52PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/18/2018	4:51PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/18/2018	4:51PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/18/2018	4:51PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/18/2018	4:50PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/18/2018	4:50PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/18/2018	4:49PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/17/2018	4:02PM	Edgar (US Regulatory)	Amended Securities Registration (section 12(b)) (8-a12b/a)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/17/2018	4:01PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/17/2018	11:45AM	PR Newswire (US)	TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/17/2018	8:56AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/17/2018	8:54AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/17/2018	8:52AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/17/2018	8:49AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/17/2018	8:47AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/10/2018	4:53PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
10/10/2018	6:30AM	PR Newswire (US)	TapImmune's HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination Study Funded b...	NASDAQ:TPIV	Marker Therapeutics (delisted)
09/25/2018	5:05PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)